CD8A and neoplasm: Several studies showed the presence of tumor-specific T cells in peripheral blood of CRC patients, comprising CD8+ T cells reactive with CRC-associated antigens including TP53, MUC1, EpCAM, HER2/neu, CEA, and heparanase [39,44,83].